E2 of hepatitis C virus inhibits apoptosis

Journal of Immunology

Volumn 175, Issue 12, 2005, Pages 8226-8235

  Lee, Song Hee ^a   Kim, Yoon Ki ^a   Kim, Chon Saeng ^a   Seol, Su Kyoung ^a   Kim, Joonhyun ^a   Cho, Sungchan ^a   Song, Young Lan ^a   Bartenschlager, Ralf ^b   Jang, Sung Key ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INHIBITOR; CYTOCHROME C; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROCASPASE 3; PROCASPASE 9; PROTEIN E2; STRUCTURAL PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; CHRONIC HEPATITIS; COLONY FORMATION; CONTROLLED STUDY; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOREGULATION; INNATE IMMUNITY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; NONHUMAN; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS MORPHOLOGY;

EID: 29144519760     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.12.8226     Document Type: Article

References (64)

1. Everett, H., and G. McFadden. 1999. Apoptosis: an innate immune response to virus infection. Trends Microbiol. 7: 160-165.
2. Clouston, W. M., and J. F. Kerr. 1985. Apoptosis, lymphocytotoxicity and the containment of viral infections. Med. Hypotheses 18: 399-404.
3. Raftery, M. J., C. K. Behrens, A. Müller, P. H. Krammer, H. Walczak, and G. Schönrich. 1999. Herpes simplex virus type 1 infection of activated cytotoxic T cells: induction of fratricide as a mechanism of viral immune evasion. J. Exp. Med. 190: 1103-1114.
4. Hasnain, S. E., R. Begum, K. V. Ramaiah, S. Sahdev, E. M. Shajil, T. K. Taneja, M. Mohan, M. Athar, N. K. Sah, and M. Krishnaveni. 2003. Host-pathogen interactions during apoptosis. J. Biosci. 28: 349-358.
5. Polyak, S. J. 2003. Hepatitis C virus: cell interactions and their role in pathogenesis. Clin. Liver Dis. 7: 67-88.
6. Benedict, C. A., P. S. Norris, and C. F. Ware. 2002. To kill or be killed: viral evasion of apoptosis. Nat. Immunol 3: 1013-1018.
7. Kroemer, G., B. Dallaporta, and M. Resche-Rigon. 1998. The mitochondrial death/life regulator in apoptosis and necrosis. Annu. Rev. Physiol. 60: 619-642.
8. Scaffidi, C., I. Schmitz, J. Zha, S. J. Korsmeyer, P. H. Krammer, and M. E. Peter. 1999. Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J. Biol. Chem. 274: 22532-22538.
9. Xu, X. N., G, R. Screaton, and A. J. McMichael. 2001. Virus infections: escape, resistance, and counterattack. Immunity 15: 867-870.
10. Nagane, M., H. J. Huang, and W. K. Cavenee. 2001. The potential of TRAIL for cancer chemotherapy. Apoptosis 6: 191-197.
11. Srivastava, R. K. 2001. TRAIL/Apo-2L: mechanisms and clinical applications in cancer. Neoplasia 3: 535-546.
12. Wajant, H., K. Pfizenmaier, and P. Scheurich. 2002. TNF-related apoptosis inducing Iigand (TRAIL) and its receptors in turnor surveillance and cancer therapy. Apoptosis 7: 449-459.
13. Grütter, M. G. 2000. Caspases: key players in programmed cell death. Curr. Opin. Struct. Biol. 10: 649-655.
14. Budihardjo, I., H. Oliver, M. Lutter, X. Luo, and X. Wang. 1999. Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell Dev. Biol. 15: 269-290.
15. L and Bcl-2. Br. J. Cancer 88: 910.
16. Benedict, C. A., T. A. Banks, and C. F. Ware. 2003. Death and survival: viral regulation of TNF signaling pathways. Curr. Opin. Immunol. 15: 59-65.
17. Bertin, J., R. C. Armstrong, S. Ottilie, D. A. Martin, Y. Wang, S. Banks, G.-H. Wang, T. G, Senkevich, E. S. Alnemri, B. Moss, et al. 1997. Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. Proc. Natl. Acad. Sci. USA 94: 1172-1176.
18. Griffith, T. S., T. Brunner, S. M. Fletcher, D. R. Green, and T. A. Fcrguson. 1995. Fas ligand-indiiced apoptosis as a mechanism of immune privilege. Science 270: 1189-1192.
19. Karp, C. L., M. Wysocka, L. M. Wahl, J. M. Ahearn, P. J. Cuomo, B. Sherry, G. Trinchieri, and D. E. Griffin. 1996. Mechanism of suppression of cell-mediated immunity by measles virus. Science 273: 228-231.
20. Shisler, J., C. Yang, B. Walter, C. F. Ware, and L. R. Gooding. 1997. The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis. J. Virol. 71: 8299-8306.
21. Barber, G. N. 2001. Host defense, viruses and apoptosis. Cell Death Differ. 8: 113-126.
22. Benedict, C. A., P. S. Norris, T. I. Prigozy, J.-L. Bodmer, J. A. Mahr. C. T. Garnett, F. Martinon, J. Tschopp, L. R. Gooding, and C. F. Ware. 2001. Three adenovirus E3 proteins cooperate to evade apoptosis by tumor necrosis factor-related apoptosis-inducing ligand receptor-1 and -2. J. Biol. Chem. 276: 3270-3278.
23. Alter, M. J., H. S. Margolis, K. Krawczynski, F. N. Judson, A. Mares, W. J. Alexander, P. Y. Hu, J. K. Miller, M. A. Gerber, R. E. Sampliner, et al. 1992. The natural history of community-acquired hepatitis C in the United States: the Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N. Engl. J. Med. 327: 1899-1905.
24. Kuo, G., Q. L. Choo, H. J. Alter, G. L. Gitnick, A. G. Redeker, R. H. Purcell, T. Miyamura, J. L. Dienstag, M. J. Alter, C. E. Stevens, et al. 1989. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244: 362-364.
25. Hoofnagle, J. H. 1997. Hepatitis C: the clinical spectrum of disease. Hepatology 26: 15S-20S.
26. Di Bisceglie, A. M., Z. D. Goodman, K. G. Ishak, J. H. Hoofnagle, J. J. Melpolder, and H. J. Alter. 1991. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology 14: 969-974.
27. Villano, S. A., D. Vlahov, K. E. Nelson, S. Cohn, and D. L. Thomas. 1999. Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection. Hepatotogy 29: 908-914.
28. Matsuura, Y., T. Harada, M. Makimura, M. Sato, H. Aizaki, T. Suzuki, and T, Miyamura. 1994. Characterization of HCV structural proteins expressed in various animal cells. Intervirology 37: 114-118.
29. Aoki, H., J. Hayashi, M. Moriyama, Y. Arakawa, and O. Hino. 2000. Hepatitis C virus core protein interacts with 14-3-3 protein and activates the kinase Raf-1. J. Virol. 74: 1736-1741.
30. Perlemuter, G., A. Sabile, P. Letteron, G. Vona, A. Topilco, Y. Chretien, K. Koike, D. Pessayre, J. Chapman, G. Barba, and C. Brechot. 2002. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis. FASEB J. 16: 185-194.
31. Sabile, A., G. Perlemuter, F. Bono, K. Kohara, F. Dematigre, M. Kohara, Y. Matsuura, T. Miyamura, C. Brechot, and G. Barba. 1999. Hepatitis C virus core protein binds to apolipoprotein AII and its secretion is modulated by fibrates. Hepatology 30: 1064-1076.
32. Chung, Y. M., K. J. Park, S. Y. Choi, S. B. Hwang, and S. Y. Lee. 2001. Hepatitis C virus core protein potentiates TNF-α-induced NF-κB activation through TRAF2-IKKβ-dependent pathway. Biochem. Biophys. Res. Commun. 284: 15-19.
33. Chou, A. H., H. F. Tsai, Y. Y. Wu, C. Y. Hu, L. H. Hwang, P. I. Hsu, and P. N. Hsu. 2005. Hepatitis C virus core protein modulates TRAIL-mediated apoptosis by enhancing Bid cleavage and activation of mitochondria apoptosis signaling pathway. J. Immunol. 174: 2160-2166.
34. Prikhod'ko, E. A., G. G. Prikhod'ko, R. M. Siegel, P. Thompson, M. E. Major, and J. L. Cohen. 2004, The NS3 protein of hepatitis C virus induces caspase-S-mediated apoptosis independent of its protease or helicase activities. Virology 329: 53-67.
35. Siavoshian, S., J. D. Abraham. C. Thumann, M. P. Kieny, and C. Schuster. 2005. Hepatitis C virus core, NS3, NS5A, NS5B proteins induce apoptosis in mature dendritic cells. J. Med. Virol. 75: 402-411.
36. Berg, T., A. Mas Marques, M. Höhne, B. Wiedenmann, U. Hopf, and E. Schreier. 2000. Mutations in the E2-PePHD and NS5A region of hepatitis C virus type 1 and the dynamics of hepatitis C viremia decline during interferon alfa treatment. Hepatology 32: 1386-1395.
37. Taylor, D. R., S. T. Shi, P. R. Romano, G. N. Barber, and M. M. Lai. 1999. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 285: 107-110.
38. Fujita, T., S. Ishido, S. Muramatsu, M. Itoh, and H. Hotta. 1996. Suppression of actinomycin D-induced apoptosis by the NS3 protein of hepatitis C virus. Biochem. Biophys. Res. Commun. 229: 825-831.
39. Park, J. S., J. M. Yang, and M. K. Min. 2000. Hepatitis C virus nonstructural protein NS4B transforms NIH3T3 cells in cooperation with the Ha-ras oncogene, Biochem. Biophys. Res. Commun. 267: 581-587.
40. Lohmann, V., F. Körner, J.-O. Koch, U. Herian, L. Theilmann, and R. Bartenschlager. 1999. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285: 110-113.
41. Krieger, N., V. Lohmann, and R. Bartenschlager. 2001. Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations. J. Virol. 75: 4614-4624.
42. Bukh, J., T. Pietschmann, V. Lohmann, N. Krieger, K. Faulk, R. E. Engle, S. Govindarajan, M. Shapiro, M. St. Claire, and R. Bartenschlager. 2002. Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees. Proc. Natl. Acad. Sci. USA 99: 14416-14421.
43. Kim, Y. K., C. S., Kim, S. H. Lee, and S. K. Jang. 2002. Domains I and II in the 5′ nontranslated region of the HCV genome are required for RNA replication. Biochem. Biophys. Res. Commun. 290: 105-112.
44. Yang, J., X, Liu, K. Bhalla, C. N. Kim, A. M. Ibrado, J. Cai, T. I. Peng, D. P. Jones, and X. Wang. 1997. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275: 1129-1132.
45. LeBlanc, H. N., and A. Ashkenazi. 2003. Apo2L/TRAIL and its death and decoy receptors. Cell Death Differ. 10: 66-75.
46. Ashkenazi, A., and V. M. Dixit. 1999. Apoptosis control by death and decoy receptors. Curr. Opin. Cell Biol. 11: 255-260.
47. L overexpression inhibits cytochrome c release, activation of multiple caspases, and virus release following coxsackievirus B3 infection. Virology 313: 147-157.
48. Fulda, S., E. Meyer, and K. M. Debatin. 2002. Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression. Oncogene 21: 2283-2294.
49. Wakita, T., T. Pietschmann, T. Kato, T. Date, M. Miyamoto, Z. Zhao, K. Murthy, A. Habermann, H.-G. Kräusslich, M. Mizokami, et al. 2005. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11: 791-796.
50. Lindenbach, B. D., M. J. Evans, A. J. Syder, B. Wölk, T. L. Tellinghuisen, C. C. Liu, T. Maruyama, R. O. Hynes, D. R. Burton, J. A. McKeating, and C. M. Rice. 2005. Complete replication of hepatitis C virus in cell culture. Science 309: 623-626.
51. Zhong, J., P. Gastaminza, G. Cheng, S. Kapadia, T. Kato, D. R. Burton, S. F. Wieland, S. L. Uprichard, T. Wakita, and F. V. Chisari. 2005. Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. USA 102: 9294-9299.
52. Molenkamp, R., E. A. Kooi, M. A. Lucassen, S. Greve, J. C. Thijssen, W. J. Spaan, and P. J. Bredenbeek. 2003. Yellow fever virus replicons as an expression system for hepatitis C virus structural proteins. J. Virol. 77: 1644-1648.
53. Greive, S. J., R. I. Webb, J. M. Mackenzie, and E. J. Gowans. 2002. Expression of the hepatitis C virus structural proteins in mammalian cells induces morphology similar to that in natural infection. J. Viral Hepat. 9: 9-17.
54. Machida, K., K. Tsukiyama-Kohara, E. Seike, S. Tone, F. Shibasaki, M. Shimizu, H. Takahashi, Y. Hayashi, N. Funata, C. Taya, et al. 2001. Inhibition of cytochrome c release in Fas-mediated signaling pathway in transgenic mice induced to express hepatitis C viral proteins. J. Biol. Chem. 276: 12140-12146.
55. Konan, K. V., T. H. Giddings, Jr., M. Ikeda, K. Li, S. M. Lemon, and K. Kirkegaard. 2003. Nonstructural protein precursor NS4A/B from hepatitis C virus alters function and ultrastructure of host secretory apparatus. J. Virol. 77: 7843-7855.
56. Fulda, S., I. Jeremias, and K. M. Debatin. 2004. Cooperation of betulinic acid and TRAIL to induce apoptosis in tumor cells. Oncogene 23: 7611-7620.
57. Hahn, C. S., Y. G. Cho, B. S. Kang, I. M. Lester, and Y. S. Hahn. 2000. The HCV core protein acts as a positive regulator of fas-mediated apoptosis in a human lymphoblastoid T cell line. Virology 276: 127-137.
58. Goh, P. Y., Y. J. Tan, S. P. Lim, S. G. Lim, Y. H. Tan, and W. J. Hong. 2001. The hepatitis C virus core protein interacts with NS5A and activates its caspase-mediated proteolytic cleavage. Virology 290: 224-236.
59. Mannová, P., and L. Beretta. 2005. Activation of the N-Ras-PI3K-Akt-mTOR pathway by hepatitis C virus: control of cell survival and viral replication. J. Virol. 79: 8742-8749.
60. Pavio, N., D. R. Taylor, and M. M. Lai. 2002. Detection of a novel unglycosylated form of hepatitis C virus E2 envelope protein that is located in the cytosol and interacts with PKR. J. Virol. 76: 1265-1272.
61. Pavio, N., P. R. Romano, T. M. Graczyk, S. M. Feinstone, and D. R. Taylor. 2003. Protein synthesis and endoplasmic reticulum stress can be modulated by the hepatitis C virus envelope protein E2 through the eukaryotic initiation factor 2α kinase PERK. J. Virol. 77: 3578-3585.
62. Teodoro, J. G., and P. E. Branton. 1997. Regulation of apoptosis by viral gene products. J. Virol 71: 1739-1746.
63. McNees, A. L., and L. R. Gooding. 2002. Adenoviral inhibitors of apoptotic cell death. Virus Res. 88: 87-101.
64. Bantel, H.. and K. Schulze-Osthoff. 2003. Apoptosis in hepatitis C virus infection. Cell Death Differ. 10: S48-S58.